
Ateroskleroz, yurak-qon tomir tizimining surunkali yallig‘lanish kasalligi, yurak-qon tomir kasalliklarining asosiy sabablaridan biri va uning oqibatlari. Ateroskleroz patogenezida turli xil yallig‘lanish mexanizmlarining roli haqida ko‘proq dalillar mavjud. Interleykin-6 aterogenezda ishtirok etadigan asosiy yallig‘lanishga qarshi sitokinlardan biridir. Biomarkerlardan foydalangan holda yurak-qon tomir kasalliklari xavfini bashorat qilishning yangi imkoniyatlariga e’tibor biotexnologiyaning jadal rivojlanishi sharoitida so‘nggi yigirma yil ichida global hamjamiyat tomonidan faol muhokama qilinmoqda.
Ateroskleroz, IL-10, IL-6, TNF, CRO., Ateroskleroz, IL-10, IL-6, TNF, CRO.
Ateroskleroz, IL-10, IL-6, TNF, CRO., Ateroskleroz, IL-10, IL-6, TNF, CRO.
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
